MET and non-small cell lung carcinoma: Interestingly, we found that LKB1mut NSCLC cell line H460 showed a higher reduction of cell viability when co-cultured with PBMCs treated with MET alone and combined with anti-PD-L1 compared to LKB1wt cells (Fig. 4A).